Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Interchangeability of Infanrix-Hexa vs DTPa-IPV/Hib + HBV in Infants
NCT00366366Phase 3Completed
- Sponsor
- GSK
- Start
- Sep 2001
- Primary completion
- Sep 2002
- Modality
- Vaccines & Immunotherapeutics
01
Overview
A Phase 3 trial of Infanrix Hexa in hepatitis B (HBV), diphtheria, Tetanus, pertussis, poliomyelitis, sponsored by GSK. Started Sep 2001; status: completed.
02
Drugs
Infanrix Hexa
03
Conditions
hepatitis B (HBV)diphtheriaTetanuspertussispoliomyelitis
Beyond the preview
Go deeper on NCT00366366.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00366366.